DSDiarmaid Mpharm Semple

Diarmaid Mpharm Semple

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diarmaid Mpharm Semple has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Cormac V. Breatnach

    Children’s Health Ireland Crumlin, Dublin, Ireland

    1 shared publication
  • Cormac V. Mb Bch Breatnach

    Department of Intensive Care, Children's Health Ireland, Crumlin, Dublin, Ireland

    1 shared publication
  • Fiona Boland

    Data Science Centre, School of Population Health, Royal College of Surgeons in Ireland, Dublin, Ireland

    1 shared publication
  • John C. Hayden

    School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

    1 shared publication
  • John C. PhD Hayden

    School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland

    1 shared publication
  • Judith D. PhD Strawbridge

    Pharmacy Department, Children’s Health Ireland, Crumlin, Dublin, Ireland

    1 shared publication

Latest Publications

  • Open Access

    Delirium in critically ill children: a retrospective pre- and post-cohort study on the introduction of delirium screening in a paediatric intensive care unit

    by Diarmaid Semple, Fiona Boland, Cormac V. Breatnach, Moninne M. Howlett, Judith D. Strawbridge, John C. Hayden

    Background: Paediatric delirium is a neuropsychiatric disorder with disrupted cerebral functioning due to underlying disease and/or critical care treatment. It has been reported in up to one third of paediatric intensive care admissions, with hypoactive delirium most prevalent in children. Aim: The aim of this study was to assess whether the introduction of delirium screening was associated with a change in the pharmacotherapy exposure and clinical outcomes. Method: A retrospective pre and post cohort study of all admissions > 48 h who required mechanical ventilation between 11th March 2019 and 11th March 2021. Cohort 1 (11th March 2019–11th March 2020) prior to the introduction of delirium screening and cohort 2 (12th March 2020–12th March 2021) after delirium screening. Patients < 3 months old, who were never mechanically ventilated, admitted p < 0.05) and midazolam (50% reduction in patients receiving p < 0.05), after screening commenced. Chloral hydrate use was unchanged however cohort 2 received lower daily doses (p < 0.05). Clonidine infusion use increased for cohort 2 (16% v 28% p < 0.05), with lower daily doses (23 v 13 µg/kg/day p < 0.05). Positive clinical outcomes such as decreased duration of mechanical ventilation, length of stay and out of range sedation and withdrawal scores were also observed. Conclusion: Introduction of a paediatric delirium care bundle including screening tool and associated education was associated with decrease in exposure to modifiable pharmacotherapy risk factors for the development of paediatric delirium. These findings should be further evaluated in future interventional studies.


  • A Systematic Review and Pooled Prevalence of Delirium in Critically Ill Children*

    by Diarmaid Mpharm Semple, Moninne M. PhD Howlett, Judith D. PhD Strawbridge, Cormac V. Mb Bch Breatnach, John C. PhD Hayden

    OBJECTIVES: Pediatric delirium is a neuropsychiatric disorder with disrupted cerebral functioning due to underlying disease and/or critical care treatment. Pediatric delirium can be classified as hypoactive, hyperactive, and mixed. This systematic review was conducted to estimate the pooled prevalence of pediatric delirium using validated assessment tools in children (Cornell Assessment of Pediatric Delirium, Pediatric Confusion Assessment Method for the ICU, PreSchool Confusion Assessment Method for the ICU, Pediatric Confusion Assessment Method for the ICU Severity Scale, and Sophia Observation Withdrawal Symptoms Pediatric Delirium scale), identify modifiable and nonmodifiable risk factors, and explore the association of pediatric delirium with clinical outcomes. Data Sources: A systematic search of PubMed, EMBASE, and CINAHL databases was undertaken for full articles pertaining to pediatric delirium prevalence. Study Selection: No language or date barriers were set. Studies were included where the following eligibility criteria were met: study design aimed to estimate pediatric delirium prevalence arising from treatment in the intensive care setting, using a validated tool. Only randomized controlled trials, cross-sectional studies, or cohort studies allowing an estimate of the prevalence of pediatric delirium were included. Data Extraction: Data were extracted by the primary researcher (D.S.) and accuracy checked by coauthors. Data Synthesis: A narrative synthesis and pooled prevalence meta-analysis were undertaken. CONCLUSIONS: Pediatric delirium, as determined by the Cornell Assessment of Pediatric Delirium score, is estimated to occur in 34% of critical care admissions. Eight of 11 studies reporting on subtype identified hypoactive delirium as most prevalent (46–81%) with each of the three remaining reporting either hyperactive (44%), mixed (57%), or equal percentages of hypoactive and mixed delirium (43%) as most prevalent. The development of pediatric delirium is associated with cumulative doses of benzodiazepines, opioids, the number of sedative classes used, deep sedation, and cardiothoracic surgery. Increased time mechanically ventilated, length of stay, mortality, healthcare costs, and associations with decreased quality of life after discharge were also found. Multi-institutional and longitudinal studies are required to better determine the natural history, true prevalence, long-term outcomes, management strategies, and financial implications of pediatric delirium.